Literature DB >> 18847337

Glioma surgery using a multimodal navigation system with integrated metabolic images.

Yoji Tanaka1, Tadashi Nariai, Toshiya Momose, Masaru Aoyagi, Taketoshi Maehara, Toshiki Tomori, Yoshikazu Yoshino, Tsukasa Nagaoka, Kiichi Ishiwata, Kenji Ishii, Kikuo Ohno.   

Abstract

OBJECT: A multimodal neuronavigation system using metabolic images with PET and anatomical images from MR images is described here for glioma surgery. The efficacy of the multimodal neuronavigation system was evaluated by comparing the results with that of the conventional navigation system, which routinely uses anatomical images from MR and CT imaging as guides.
METHODS: Thirty-three patients with cerebral glioma underwent 36 operations with the aid of either a multimodal or conventional navigation system. All of the patients were preliminarily examined using PET with l-methyl-[11C] methionine (MET) for surgical planning. Seventeen of the operations were performed with the multimodal navigation system by integrating the MET-PET images with anatomical MR images. The other 19 operations were performed using a conventional navigation system based solely on MR imaging.
RESULTS: The multimodal navigation system proved to be more useful than the conventional navigation system in determining the area to be resected by providing a clearer tumor boundary, especially in cases of recurrent tumor that had lost a normal gyral pattern. The multimodal navigation system was therefore more effective than the conventional navigation system in decreasing the mass of the tumor remnant in the resectable portion. A multivariate regression analysis revealed that the multimodal navigation system-guided surgery benefited patient survival significantly more than the conventional navigation-guided surgery (p = 0.016, odds ratio 0.52 [95% confidence interval 0.29-0.88]).
CONCLUSIONS: The authors' preliminary intrainstitutional comparison between the 2 navigation systems suggested the possible premise of multimodal navigation. The multimodal navigation system using MET-PET fusion imaging is an interesting technique that may prove to be valuable in the future.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18847337     DOI: 10.3171/2008.4.17569

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  31 in total

Review 1.  Non-invasive metabolic imaging of brain tumours in the era of precision medicine.

Authors:  Michelle M Kim; Abhijit Parolia; Mark P Dunphy; Sriram Venneti
Journal:  Nat Rev Clin Oncol       Date:  2016-07-19       Impact factor: 66.675

2.  A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.

Authors:  Makoto Ideguchi; Takafumi Nishizaki; Norio Ikeda; Tomomi Okamura; Yasue Tanaka; Natsumi Fujii; Machiko Ohno; Taichi Shimabukuro; Tokuhiro Kimura; Eiji Ikeda; Kazuyoshi Suga
Journal:  J Neurooncol       Date:  2018-03-07       Impact factor: 4.130

Review 3.  Molecular imaging of gliomas with PET: opportunities and limitations.

Authors:  Christian la Fougère; Bogdana Suchorska; Peter Bartenstein; Friedrich-Wilhelm Kreth; Jörg-Christian Tonn
Journal:  Neuro Oncol       Date:  2011-07-13       Impact factor: 12.300

4.  Comparison of 11C-methionine PET and 18F-FDG PET in patients with primary central nervous system lymphoma.

Authors:  Yoshiro Kawase; Yuka Yamamoto; Reiko Kameyama; Nobuyuki Kawai; Nobuyuki Kudomi; Yoshihiro Nishiyama
Journal:  Mol Imaging Biol       Date:  2011-12       Impact factor: 3.488

Review 5.  Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs.

Authors:  C von Neubeck; A Seidlitz; H H Kitzler; B Beuthien-Baumann; M Krause
Journal:  Br J Radiol       Date:  2015-07-10       Impact factor: 3.039

6.  Upfront chemotherapy and subsequent resection for molecularly defined gliomas.

Authors:  Hikaru Sasaki; Yuichi Hirose; Takahito Yazaki; Yohei Kitamura; Makoto Katayama; Tokuhiro Kimura; Hirokazu Fujiwara; Masahiro Toda; Takayuki Ohira; Kazunari Yoshida
Journal:  J Neurooncol       Date:  2015-05-26       Impact factor: 4.130

Review 7.  Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.

Authors:  Nathalie L Albert; Michael Weller; Bogdana Suchorska; Norbert Galldiks; Riccardo Soffietti; Michelle M Kim; Christian la Fougère; Whitney Pope; Ian Law; Javier Arbizu; Marc C Chamberlain; Michael Vogelbaum; Ben M Ellingson; Joerg C Tonn
Journal:  Neuro Oncol       Date:  2016-04-21       Impact factor: 12.300

8.  Intraoperative DTI and brain mapping for surgery of neoplasm of the motor cortex and the corticospinal tract: our protocol and series in BrainSUITE.

Authors:  Giancarlo D'Andrea; Albina Angelini; Andrea Romano; Antonio Di Lauro; Giovanni Sessa; Alessandro Bozzao; Luigi Ferrante
Journal:  Neurosurg Rev       Date:  2012-02-28       Impact factor: 3.042

9.  Prognostic value of volume-based measurements on (11)C-methionine PET in glioma patients.

Authors:  Kentaro Kobayashi; Kenji Hirata; Shigeru Yamaguchi; Osamu Manabe; Shunsuke Terasaka; Hiroyuki Kobayashi; Tohru Shiga; Naoya Hattori; Shinya Tanaka; Yuji Kuge; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-04-08       Impact factor: 9.236

10.  [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.

Authors:  Markus Hutterer; Martha Nowosielski; Daniel Putzer; Nathalie L Jansen; Marcel Seiz; Michael Schocke; Mark McCoy; Georg Göbel; Christian la Fougère; Irene J Virgolini; Eugen Trinka; Andreas H Jacobs; Günther Stockhammer
Journal:  Neuro Oncol       Date:  2013-01-17       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.